Kyverna Therapeutics, Inc. (Kyverna), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell ...
Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn ...
Moderna jolted investors by pushing back its profitability forecast two years, to 2028, and announcing a $1.1 billion cut in R&D spending.
Bettersize Instruments, a leading manufacturer of particle analysis instrumentation, will host an informative webinar on ...
If automation is to become a key partner in experiment design and a core component of modern lab infrastructure, it is ...
Invenra Inc. is pleased to announce the addition of three distinguished professionals to its Board of Directors: Saira Ramasastry, Heather Preston, MD, and William Hinshaw. Together, these leaders ...
Similarly, whilst GlaxoSmithKline’s origins can be traced ... set up a pharmaceutical business in 1876. He was a pioneer of new methods in the industry, being one of the first to focus on ...
GSK has turned to Brooke Shields to get the message out about shingles vaccination. The drugmaker has worked with the model and actor to talk to female celebrities and patients aged 50 years and ...
GSK touts co-administration data for RSV, shingles vaccines as narrowed CDC guidance threatens sales
This summer, GSK cut its yearly vaccine sales projection on the back of a narrowed recommendation for adult respiratory syncytial virus (RSV) vaccines from the Centers for Disease Control and ...
The pioneering DNA testing firm has been struggling to stay afloat financially despite ambitious ventures to provide health ...
GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV) infections, which reveal a sharp decline in the proportion of patients with undetectable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback